Skip to main content
. 2019 May 16;10(6):386. doi: 10.1038/s41419-019-1612-3

Fig. 1. TRPV4 agonist induces microglial cell and astrocyte activation.

Fig. 1

a, b Icv. of TRPV4 agonist GSK1016790A markedly increased the protein levels of Iba-1 (a) and GFAP (b) in hippocampi. c, d The numbers of total and activated Iba-1+ (c, black arrow) and GFAP+ cells (d, red arrow) in hippocampal CA1 and CA3 areas in control and GSK1016790A-injected mice. Iba-1+ and GFAP+ cells (inset) in GSK1016790A-injected mice reflect the activation state of microglia and astrocyte. Scale bar = 50 μm **P < 0.01 vs. control